Retinal disease drugs

These companies develop drugs for retinal diseases such as macular degeneration.
+16.8%
over 3 months · S&P 500 −2.1%

Key indicators

Health
48 / 100
Fragile
Solid
Price
P/E 17
Cheap
Expensive
Up over 1 year
9 of 14
Volatility
77%
Calm
Choppy
Health and price: against the other tags.